{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:26:14Z","timestamp":1790792774489,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100010232","name":"National Institute of Development Administration","doi-asserted-by":"publisher","award":["UM1DA049412"],"award-info":[{"award-number":["UM1DA049412"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010232","name":"National Institute of Development Administration","doi-asserted-by":"publisher","award":["1K23DA044324\u201001"],"award-info":[{"award-number":["1K23DA044324\u201001"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Women have historically been under\u2010represented in clinical research, but the extent to which this is true for substance use disorder (SUD) trials is unknown. We aimed to determine the ratio of female:male participation in clinical trials for SUDs and describe the reporting of sex\u2010specific outcomes from 2010 to 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A retrospective cohort review of clinical trials involving people with SUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Clinical trials including people with SUD registered in\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">clinicaltrials.gov<\/jats:ext-link>\n                      and completed between 1\u2009January 2010 and 31\u2009December 2019 were reviewed. Trials were excluded if they had &lt;\u200930 participants, focused on SUD prevention, were conducted outside the United States and\/or did not report data on participant sex or gender.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>The following were extracted for each trial: primary outcome, number of participants enrolled, analytical sample size, percentage of participants who were female, inclusion of transgender participants, whether sex\u2010based analyses were performed, funding source, type of SUD and type of intervention. Relative representation in trials was examined using the female:male ratio, reported using median ratios and by year of trial completion. The proportion of females participating was adjusted using the underlying disease prevalence among females using National Survey on Drug Use and Health data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>A total of 316 trials met inclusion criteria: 274 were mixed\u2010sex, 12 enrolled only males and 30 only females. In 274 mixed\u2010sex trials, 40% of 57\u2009544 participants were female. Only 22 trials (8%) reported any sex\u2010specific analyses; four studies (1.5%) reported inclusion of transgender participants. Females represented 35% of participants in trials targeting illicit drug use disorder, 52% in nicotine use disorder and 29% in alcohol use disorder. Accounting for underlying disease prevalence revealed that women had the lowest relative enrollment in alcohol use disorder trials (median participation to prevalence ratio in 2017: 0.58; 95% confidence interval: 0.13, 0.91).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A review of 316 US clinical trials for alcohol, nicotine and illicit substance use disorders completed between 2010 and 2019 showed that females were enrolled at lower rates than males overall. Only 8% of the trials reviewed reported sex\u2010specific analyses and 1.5% reported transgender participants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.15842","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T04:32:22Z","timestamp":1644899542000},"page":"2583-2590","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The representation of females in clinical trials for substance use disorder conducted in the United States (2010\u201319)"],"prefix":"10.1111","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-2834","authenticated-orcid":false,"given":"Christine M.","family":"Gunn","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, Women's Health Unit Boston University School of Medicine  Boston MA USA"},{"name":"Department of Health Law, Policy and Management Boston University School of Public Health  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Pankowska","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, Women's Health Unit Boston University School of Medicine  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine Boston University School of Medicine  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Helsing","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, Women's Health Unit Boston University School of Medicine  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"Battaglia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, Women's Health Unit Boston University School of Medicine  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7524-0178","authenticated-orcid":false,"given":"Sarah M.","family":"Bagley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, Department of Pediatrics, Division of General Pediatrics Boston University School of Medicine  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,2,27]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2006.15.1123"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.025"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000842"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2016.01.708"},{"key":"e_1_2_9_6_1","volume-title":"Women's Health Research: Progress, Pitfalls, and Promise","author":"Institute of Medicine (US) Committee on Women's Health Research","year":"2010"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.366"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.01.001"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-4-S1-S8"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13985"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12784"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.07.007"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-018-0598-0"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.12.037"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.09.005"},{"key":"e_1_2_9_16_1","unstructured":"Centers for Disease Control and Prevention. Prescription Painkiller Overdoses: A Growing Epidemic Especially Among Women.2013. Available at:https:\/\/www.cdc.gov\/vitalsigns\/prescriptionpainkilleroverdoses\/index.html(accessed 26 September 2017)."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12815"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.010"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430706"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.043594"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.596875"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14440"},{"key":"e_1_2_9_23_1","unstructured":"World Drug Report 2019. United Nations. Available at:https:\/\/wdr.unodc.org\/wdr2019\/prelaunch\/WDR19_Booklet_2_DRUG_DEMAND.pdf"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1768-8"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.070"},{"key":"e_1_2_9_26_1","unstructured":"National Survey on Drug Use and Health 2019. US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality.2020. Available at:https:\/\/datafiles.samhsa.gov\/(accessed 3 April 2020)."},{"key":"e_1_2_9_27_1","unstructured":"National Institute on Drug Abuse. Successfully Including Women in Clinical Trials: A Guide for Researchers. 2011. Available at:https:\/\/www.drugabuse.gov\/sites\/default\/files\/womens-brochure_1025-004_508.pdf(accessed 23 April 2021)."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.01.017"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.16405"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-016-0007-6"},{"key":"e_1_2_9_31_1","unstructured":"Official Journal of the European Union. Regulation 536\/2014.2014. Available at:https:\/\/ec.europa.eu\/health\/sites\/default\/files\/files\/eudralex\/vol-1\/reg_2014_536\/reg_2014_536_en.pdf(accessed 4 January 2022)."},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.10076"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.1156"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.05.012"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.15842","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.15842","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.15842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:27:08Z","timestamp":1692656828000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.15842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1111\/add.15842"],"URL":"https:\/\/doi.org\/10.1111\/add.15842","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,27]]},"assertion":[{"value":"2021-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}